Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

NCT00642655 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: IVIG and Rituximab

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]
[object Object]